Clinical Infectious Diseases · 2015 · 202 citations · 12 references
Antibiotic AdministrationDysbiosisHuman Microbial FloraFecal MicrobiotaDrug ResistanceProbioticLong-term EffectGut MicrobiologyMicrobial EcologyIntestinal MicrobiotaAntimicrobial ResistanceHuman MicrobiotaPyrosequencing MethodsMicrobiomePharmacologyNormal MicrobiotaAntimicrobial SusceptibilityAntibioticsMicrobiologyGut BarrierMedicine
The purpose of the study was to assess the effect of ciprofloxacin (500 mg twice daily for 10 days) or clindamycin (150 mg 4 times daily for 10 days) on the fecal microbiota of healthy humans for a period of 1 year as compared to placebo. Two different methods, culture and microbiome analysis, were used. Fecal samples were collected for analyses at 6 time-points. The interval needed for the normal microbiota to be normalized after ciprofloxacin or clindamycin treatment differed for various bacterial species. It took 1-12 months to normalize the human microbiota after antibiotic administration, with the most pronounced effect on day 11. Exposure to ciprofloxacin or clindamycin had a strong effect on the diversity of the microbiome, and changes in microbial composition were observed until the 12th month, with the most pronounced microbial shift at month 1. No Clostridium difficile colonization or C. difficile infections were reported. Based on the pyrosequencing results, it appears that clindamycin has more impact than ciprofloxacin on the intestinal microbiota.
12
Manual of Clinical Microbiology.
Annals of Internal Medicine · 1980 · 14.5K citations
Medical Microbiology, Pathogenic Microbiology, Microbial Disease +12
Defining the healthy "core microbiome" of oral microbial communities
Egija Zaura, Bart J. F. Keijser, Susan M. Huse et al. · BMC Microbiology · 2009 · 1.3K citations · Full text
The Relation between Oral Candida Load and Bacterial Microbiome Profiles in Dutch Older Adults
Eefje A. Kraneveld, Mark J. Buijs, Marc Jan Bonder et al. · PLoS ONE · 2012 · 111 citations · Full text